Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment

Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment

Bibliographic Details
Main Authors:	Sinadinos, A, Sergijenko, A, Meng, C, Gamlin, T, Hyde, S, Gill, DR, Griesenbach, U, Alton, EWFW
Format:	Conference item
Language:	English
Published:	Cell Press 2021

Similar Items

Development of protocols for mouse GLP-toxicology studies
by: Sinadinos, A, et al.
Published: (2020)

597: Protocol development for mouse toxicology studies using lentiviral gene therapy
by: Sinadinos, A, et al.
Published: (2021)

Assessment of the air-liquid interface culture model as a tool to validate efficacy of a rSIV.F/HN-CFTR vector
by: Sergijenko, A, et al.
Published: (2021)

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients
by: Sergijenko, A, et al.
Published: (2020)

Gene therapy for respiratory diseases; progress and a changing context
by: Alton, EWFW, et al.
Published: (2020)

Low titer lentiviral transgenesis in rodents with simian immundeficiency virus vector
by: Balázs Bender, et al.
Published: (2013-09-01)

Lung-targeted lentiviral vector mediates passive immunisation against influenza
by: Tan, T, et al.
Published: (2018)

Correction of a chronic pulmonary disease through lentiviral vector-mediated protein expression
by: Helena Lund-Palau, et al.
Published: (2022-06-01)

Lung-targeting lentiviral vector for passive immunisation against influenza
by: Tan, TK, et al.
Published: (2020)

Cholesterol as an enhancer of lentiviral vector production in serum-free transient transfection
by: Gelinas, J, et al.
Published: (2013)

Assessment of selected media supplements to improve F/HN lentiviral vector production yields
by: Gélinas, J, et al.
Published: (2017)

Rapid determination of rSIV.F/HN lentiviral vector titre
by: Conway, CC, et al.
Published: (2020)

Single cell assays for quantifying MRNA and protein during cystic fibrosis gene therapy trials
by: Sinadinos, A, et al.
Published: (2020)

Large-scale, high-throughput production of lentiviral vectors for multiple disease applications
by: Ashworth, R, et al.
Published: (2018)

Lentiviral Vector Bioprocessing
by: Christopher Perry, et al.
Published: (2021-02-01)

Production of lentiviral vectors
by: Otto-Wilhelm Merten, et al.
Published: (2016-01-01)

Advances of Lentiviral Vectors
by: Fanrong MENG, et al.
Published: (2014-12-01)

A method for assessing the distribution of eGFP expressing cells in the mouse lung following lentiviral vector transduction
by: Munday, R, et al.
Published: (2018)

High levels of native eGFP detected following F/HN lentiviral vector transduction of a variety of lung models
by: Munday, R, et al.
Published: (2019)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
by: Antepowicz, A, et al.
Published: (2021)

The very stable lentiviral vector
by: Gwendolyn K. Binder, et al.
Published: (2024-03-01)

Special Issue “Lentiviral Vectors”
by: Yasuhiro Takeuchi
Published: (2022-07-01)

The Inside Out of Lentiviral Vectors
by: Stéphanie Durand, et al.
Published: (2011-02-01)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
by: Agata Antepowicz, et al.
Published: (2021-08-01)

TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
by: Griesenbach, U, et al.
Published: (2011)

Enhanced lentiviral production through rational design of mammalian host cells
by: Hyde, S, et al.
Published: (2016)

Lentiviral Vectors for Ocular Gene Therapy
by: Yvan Arsenijevic, et al.
Published: (2022-07-01)

Comparison of lentiviral vector titration methods
by: Debyser Zeger, et al.
Published: (2006-07-01)

An Improved Protocol for the Production of Lentiviral Vectors
by: Logan Y. Brown, et al.
Published: (2020-12-01)

Rev-dependent lentiviral expression vector
by: Beddall Margaret H, et al.
Published: (2007-02-01)

Effective gene therapy with nonintegrating lentiviral vectors.
by: Yáñez-Muñoz, R, et al.
Published: (2006)

Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance
by: Inès Dufait, et al.
Published: (2012-01-01)

Lentiviral Vectors and Cystic Fibrosis Gene Therapy
by: Massimo Conese, et al.
Published: (2010-01-01)

Lentiviral Vector Gene Transfer to Porcine Airways
by: Patrick L Sinn, et al.
Published: (2012-01-01)

Lentiviral vector pseudotyped with sendai virus F and HN proteins uses sialylated glycan receptors to efficiently target human airway cells
by: Munday, RJ, et al.
Published: (2020)

F/HN pseudotyped lentiviral vector uses alpha 2,3 sialylated N-acetyllactosamine to efficiently transduce human airway cells
by: Munday, RJ, et al.
Published: (2022)

Moving lentiviral-based gene therapy into a first-in-man CF trial
by: Griesenbach, D, et al.
Published: (2015)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
by: Alton, E, et al.
Published: (2014)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
by: Alton, E, et al.
Published: (2014)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
by: Munday, RJ, et al.
Published: (2022)